Mesirow Financial Investment Management, Inc. Sangamo Therapeutics, Inc Transaction History
Mesirow Financial Investment Management, Inc.
- $4.79 Billion
- Q4 2024
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 11,800 shares of SGMO stock, worth $9,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,800
Previous 11,800
-0.0%
Holding current value
$9,676
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SGMO
# of Institutions
141Shares Held
60.4MCall Options Held
1.46MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA9.37MShares$7.69 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT9.23MShares$7.57 Million0.05% of portfolio
-
State Street Corp Boston, MA5.02MShares$4.12 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$3.86 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$2.53 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $128M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...